Loading...

OTC Markets

Totals

Securities

12,288

Dollar Vol

$2.9B

Share Vol

3.9B

Trades

412,972

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
HXBM
Financials

HXBM
Helix BioMedix, Inc.

Common Stock

3.50

0.00

0.00%

3.39 / 4.00 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 10/08/2025

Delayed (15 Min) Trade Data: 12:00am 09/24/2025

Financials

Fiscal year ends 12/31

| Values in 000s USD

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

2024

12/30/2024

2023

12/30/2023

2022

12/30/2022

2021

12/30/2021

12/30/2024

2024-12-31 00:00:00

12/30/2023

2024-12-31 00:00:00

12/30/2022

2024-12-31 00:00:00

12/30/2021

2024-12-31 00:00:00

Revenues

Total Revenue

804

997

804

1,754

804

2,373

804

Cost of Revenue

430

Gross Profit

804

997

804

1,751

804

1,942

804

Operating Expenses

Research and Development

510

317

510

891

510

1,238

510

Sales, General and Admin

1,294

1,654

1,294

1,925

1,294

1,920

1,294

Non-Recurring Items

Other

133

140

106

Total Expenses

1,868

2,105

1,868

2,958

1,868

3,266

1,868

Operating Income

(1,064)

(1,107)

(1,064)

(1,206)

(1,064)

(1,323)

(1,064)

Income from Continuing Operations

Additional Income / Expense Items

Earnings Before Interest and Taxes

(1,064)

(1,107)

(1,064)

(1,206)

(1,064)

(1,323)

(1,064)

Interest Expense

(351)

Earnings Before Tax

(982)

(1,056)

(982)

(1,203)

(982)

(1,381)

(982)

Income Tax

Minority Interest

Equity Earnings

Net Income Cont. Operations

(982)

(1,056)

(982)

(1,192)

(982)

(1,360)

(982)

Non-Recurring Events

Discontinued Operations

Extraordinary Operations

Effect of Accounting Changes

Net Income

(982)

(1,056)

(982)

(1,192)

(982)

(1,360)

(982)

Key Financial Ratios

Earnings Per Share

Price/Earnings

Gross Margin

0.9984

0.8186

Operating Margin

-1.3232

-1.11

-1.3232

-0.6875

-1.3232

-0.5575

-1.3232

Financial data presented is provided by Edgar Online and may differ from information contained in the issuer's annual and periodic reports, which are available under the "Disclosure" tab.

Neither the issuer nor OTC Markets Group is liable for any errors, omissions or other defects in the data presented below, or for any decisions taken in reliance of the data.

For information not originally reported in U.S. Dollars, conversion is based on applicable exchange rate on the last day of the period reported.

© 2025 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Market Groups Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.